{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T17:56:36Z","timestamp":1788976596945,"version":"build-2803163510"},"reference-count":41,"publisher":"Informa UK Limited","issue":"10","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Pharmacoeconomics &amp; Outcomes Research"],"published-print":{"date-parts":[[2025,11,26]]},"DOI":"10.1080\/14737167.2025.2550426","type":"journal-article","created":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T14:53:00Z","timestamp":1755701580000},"page":"1505-1512","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":1,"title":["Cost-effectiveness of durvalumab with or without olaparib as a first-line treatment for dMMR type of advanced\/recurrent endometrial cancer"],"prefix":"10.1080","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-8556-6809","authenticated-orcid":false,"given":"Jerusha","family":"Daggolu","sequence":"first","affiliation":[{"name":"University of Houston","place":["Houston, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javeria","family":"Khalid","sequence":"additional","affiliation":[{"name":"University of Houston","place":["Houston, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Chen","sequence":"additional","affiliation":[{"name":"University of Houston","place":["Houston, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moosa","family":"Tatar","sequence":"additional","affiliation":[{"name":"University of Houston","place":["Houston, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2025,8,20]]},"reference":[{"key":"e_1_3_5_3_1","unstructured":"Center for Disease Control and Prevention. Uterine Cancer Statistics. CDC. [cited 2025 Feb 16]. Available from: https:\/\/www.cdc.gov\/uterine-cancer\/statistics\/index.html"},{"key":"e_1_3_5_4_1","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.2565"},{"key":"e_1_3_5_5_1","unstructured":"American Cancer Society. Key statistics for endometrial cancer. American Cancer Society. [cited 2025 Feb 16]. Available from: https:\/\/www.cancer.org\/cancer\/types\/endometrial-cancer\/about\/key-statistics.html"},{"key":"e_1_3_5_6_1","unstructured":"Cancer Treatment Centers of America. Stages of uterine cancer. CancerCenter. [cited 2025 Feb 16]. Available from: https:\/\/www.cancercenter.com\/cancer-types\/uterine-cancer\/stages"},{"key":"e_1_3_5_7_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13102434"},{"key":"e_1_3_5_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2022.11.031"},{"key":"e_1_3_5_9_1","doi-asserted-by":"publisher","DOI":"10.1136\/ijgc-2020-002230"},{"key":"e_1_3_5_10_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.20.01076"},{"key":"e_1_3_5_11_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2020.4515"},{"key":"e_1_3_5_12_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2216334"},{"key":"e_1_3_5_13_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.22.00975"},{"key":"e_1_3_5_14_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.23.02132"},{"key":"e_1_3_5_15_1","unstructured":"U.S. Food and Drug Administration. Fda approves durvalumab with chemotherapy for mismatch repair-deficient primary advanced or recurrent endometrial cancer. U.S. Food and Drug Administration. [cited 2025 Feb 19]. Available from: https:\/\/www.fda.gov\/drugs\/resources-information-approved-drugs\/fda-approves-durvalumab-chemotherapy-mismatch-repair-deficient-primary-advanced-or-recurrent"},{"key":"e_1_3_5_16_1","doi-asserted-by":"publisher","DOI":"10.1017\/S0266462313000160"},{"key":"e_1_3_5_17_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-11-139"},{"key":"e_1_3_5_18_1","unstructured":"Centers for Medicare & Medicaid Services. Asp drug pricing files. Published 2024. [cited 2025 Feb 12]. Available from: https:\/\/www.cms.gov\/medicare\/payment\/part-b-drugs\/asp-pricing-files"},{"key":"e_1_3_5_19_1","doi-asserted-by":"publisher","DOI":"10.1080\/13696998.2021.1917140"},{"key":"e_1_3_5_20_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1267322"},{"key":"e_1_3_5_21_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.0037"},{"key":"e_1_3_5_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2022.06.015"},{"key":"e_1_3_5_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2021.05.038"},{"key":"e_1_3_5_24_1","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2020.7796"},{"key":"e_1_3_5_25_1","unstructured":"Centers for Disease Control and Prevention. Medicare physician fee schedule. Atlanta (GA): Centers for Disease Control and Prevention. Published 2023. 2023 [cited 2025 Jan 6]. Available from: https:\/\/www.cms.gov\/medicare\/medicare-fee-for-service-payment\/feeschedulegeninfo"},{"key":"e_1_3_5_26_1","doi-asserted-by":"publisher","DOI":"10.1136\/ijgc-2020-001550"},{"key":"e_1_3_5_27_1","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2022.881034"},{"key":"e_1_3_5_28_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1391896"},{"key":"e_1_3_5_29_1","unstructured":"National Health Statistics Reports Number 122 December 20. 2025 [cited 2018 Jan 14]."},{"key":"e_1_3_5_30_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.35123"},{"key":"e_1_3_5_31_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2302312"},{"key":"e_1_3_5_32_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.22.02671"},{"key":"e_1_3_5_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2024.01.010"},{"key":"e_1_3_5_34_1","doi-asserted-by":"publisher","DOI":"10.1377\/hlthaff.2017.1032"},{"key":"e_1_3_5_35_1","unstructured":"Pietrangelo A. The value and cost of immunotherapy cancer treatments. Healthline. [cited 2025 Jan 9]. Available from: https:\/\/www.healthline.com\/health-news\/value-and-cost-of-immunotherapy"},{"key":"e_1_3_5_36_1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21443"},{"key":"e_1_3_5_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2018.12.003"},{"key":"e_1_3_5_38_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2018.5449"},{"key":"e_1_3_5_39_1","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2020.7621"},{"key":"e_1_3_5_40_1","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2023.1046424"},{"key":"e_1_3_5_41_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40261-022-01157-3"},{"key":"e_1_3_5_42_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12962-023-00429-9"},{"key":"e_1_3_5_43_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-86021-y"}],"container-title":["Expert Review of Pharmacoeconomics &amp; Outcomes Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14737167.2025.2550426","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T11:46:00Z","timestamp":1764589560000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14737167.2025.2550426"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,20]]},"references-count":41,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,11,26]]}},"alternative-id":["10.1080\/14737167.2025.2550426"],"URL":"https:\/\/doi.org\/10.1080\/14737167.2025.2550426","relation":{},"ISSN":["1473-7167","1744-8379"],"issn-type":[{"value":"1473-7167","type":"print"},{"value":"1744-8379","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,20]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierp20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierp20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-04-21","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-08-18","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-08-20","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}